person · Reporting owner
Riggsbee Richard Bryan
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CareDx, Inc.CDNA · Entity 4344 | Director | June 12, 2026 | June 16, 2026 |
| NEOGEN CORPNEOG · Entity 4338 | CFO | August 14, 2026 | August 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CareDx, Inc.
Report date June 12, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 39,312 |
Reported balance
After 2026-06-12 transaction · row 1
1 source rowRow 1 · 2026-06-12 · Grant · Acquired 9,795 · Balance 39,312 F1: The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.
NEOGEN CORP
Report date August 14, 2026 · Filed August 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 51,502 |
Reported balance
After 2026-08-14 transaction · row 1
1 source rowRow 1 · 2026-08-14 · Grant · Acquired 51,502 · Balance 51,502 F2: PSUs vest in total at the end of the three year anniversary date of the grant |
| Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.65 · Expires 2036-08-14 | Direct | 261,702 |
Reported balance
After 2026-08-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-14 · Grant · Acquired 261,702 · Balance 261,702 F1: Options vest in equal annual installments on each of the first three anniversary dates of the grants |
Filing footnotes · ownership attribution and instrument terms
F1: Options vest in equal annual installments on each of the first three anniversary dates of the grants
F2: PSUs vest in total at the end of the three year anniversary date of the grant
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MYRIAD GENETICS INC
Report date January 29, 2024 · Filed January 31, 2024
Section 16 reporting ended · disclosed 2024-01-31. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 291,812 |
Reported balance
Holding disclosure · report date 2024-01-29 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 291,812 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2020 Filed Sep 28, 2020 16:42 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 6,653 | $12.44 | $82,763.32 |
DisclosureSEC source: 0001621899-20-000008 · edgardoc.xml · nonDerivative · entry 3 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,571 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2020 Filed Sep 28, 2020 16:42 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,267 | $12.44 | $65,521.48 |
DisclosureSEC source: 0001621899-20-000008 · edgardoc.xml · nonDerivative · entry 2 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,224 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 24, 2020 Filed Sep 28, 2020 16:42 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 41,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-20-000008 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,491 F1 · kind: Consists of performance stock units granted pursuant to the Companys 2017 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 25, 2019, subject to accomplishment of pre-determined financial performance requirements. On September 24, 2020, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Companys common stock, and vests 25% on September 26, 2020, 25% on September 26, 2021, 25% on September 26, 2022, and 25% on September 26, 2023. Read SEC document |
| August 12, 2020 Filed Aug 17, 2020 20:12 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 13,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-20-000006 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,491 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 50% on August 25, 2021, and 50% on August 25, 2022. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 23:34 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-20-000002 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,204 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on February 18, 2021, 25% on February 18, 2022, 25% on February 18, 2023, and 25% on February 18, 2024. Read SEC document |
| October 22, 2019 Filed Jul 7, 2020 22:53 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GiftCommon Stock | 500 | $30.39 | $15,195.00 |
DisclosureSEC source: 0001621899-20-000004 · edgardoc.xml · nonDerivative · entry 2 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,704 Read SEC document |
| October 17, 2019 Filed Jul 7, 2020 22:53 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GiftCommon Stock | 2,000 | $29.91 | $59,820.00 |
DisclosureSEC source: 0001621899-20-000004 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,204 Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 22:50 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,289 | $28.63 | $151,424.07 |
DisclosureSEC source: 0001621899-19-000008 · edgardoc.xml · nonDerivative · entry 2 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,204 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 22:50 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 6,653 | $28.63 | $190,475.39 |
DisclosureSEC source: 0001621899-19-000008 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,493 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 20:12 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 6,653 | $29.93 | $199,124.29 |
DisclosureSEC source: 0001621899-19-000006 · edgardoc.xml · nonDerivative · entry 3 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,146 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 20:12 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,267 | $29.93 | $157,641.31 |
DisclosureSEC source: 0001621899-19-000006 · edgardoc.xml · nonDerivative · entry 2 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,799 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 20:12 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 47,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-19-000006 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,066 F1 · kind: Consists of performance stock units granted pursuant to the Companys 2017 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 19, 2018, subject to accomplishment of pre-determined financial performance requirements. On September 25, 2019, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2019, 25% on September 25, 2020, 25% on September 25, 2021, and 25% on September 25, 2022. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 20:32 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 25,000 | $41.50 | $1,037,575.00 |
DisclosureSEC source: 0001621899-19-000004 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,566 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| October 25, 2018 Filed Jun 14, 2019 16:57 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GiftCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-19-000002 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,566 Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 15:46 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 3,327 | $44.45 | $147,885.15 |
DisclosureSEC source: 0001621899-18-000010 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,966 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 12:49 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 6,653 | $46.00 | $306,038.00 |
DisclosureSEC source: 0001621899-18-000008 · edgardoc.xml · nonDerivative · entry 2 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,293 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 12:49 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,289 | $46.00 | $243,294.00 |
DisclosureSEC source: 0001621899-18-000008 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,946 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:36 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 6,653 | $46.65 | $310,362.45 |
DisclosureSEC source: 0001621899-18-000006 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,235 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 16:06 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-18-000004 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,888 F1 · kind: Consists of performance stock units granted pursuant to the Companys 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 17, 2017, subject to accomplishment of pre-determined financial performance requirements. On September 19, 2018, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021. Read SEC document |
| June 26, 2018 Filed Jul 13, 2018 20:21 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-18-000002 · edgardoc.xml · nonDerivative · entry 3 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,888 Read SEC document |
| June 25, 2018 Filed Jul 13, 2018 20:21 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-18-000002 · edgardoc.xml · nonDerivative · entry 2 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,188 Read SEC document |
| June 22, 2018 Filed Jul 13, 2018 20:21 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-18-000002 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,688 Read SEC document |
| October 17, 2017 Filed Oct 17, 2017 21:45 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 3,522 | $35.84 | $126,228.48 |
DisclosureSEC source: 0001621899-17-000006 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,988 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 20:40 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,599 | $36.18 | $202,571.82 |
DisclosureSEC source: 0001621899-17-000004 · edgardoc.xml · nonDerivative · entry 2 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,510 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 20:40 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 7,043 | $36.18 | $254,815.74 |
DisclosureSEC source: 0001621899-17-000004 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,109 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:39 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-17-000002 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,152 F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 14, 2016, subject to accomplishment of pre-determined financial performance requirements. On September 13, 2017, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020. Read SEC document |
| October 17, 2016 Filed Oct 17, 2016 23:09 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 3,522 | $19.31 | $68,009.82 |
DisclosureSEC source: 0001621899-16-000008 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,152 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 21:51 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,599 | $20.58 | $115,227.42 |
DisclosureSEC source: 0001621899-16-000006 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,674 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 17:46 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 47,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-16-000004 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,273 F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2016, 25% on September 30, 2017, 25% on September 30, 2018, and 25% on September 30, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.